Pricing Log in Create free account

Cellectis S.A. (CLLS) vs Tiziana Life Sciences Ltd (TLSA)

Cellectis S.A. and Tiziana Life Sciences Ltd are both Biotechnology companies. Cellectis S.A. and Tiziana Life Sciences Ltd are of similar size ($84.6M and $81.9M). Tiziana Life Sciences Ltd has the higher net margin (0.00% vs −102.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Tiziana Life Sciences Ltd leads on 8 and Cellectis S.A. on 3.

Valuation

Metric CLLS TLSA Biotechnology median
P/E n/m n/m 10.26
P/S 1.59 — 9.18
P/B 2.48 n/m 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 0.04 0.65
EV/Sales 0.13 n/m 8.98
Earnings yield (64.76%) (84.48%) (34.89%)
Free cash flow yield (45.45%) 0.00% (24.52%)

Profitability

Metric CLLS TLSA Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (90.88%) — 0.00%
Net margin (102.34%) 0.00% 0.00%
Free cash flow margin (68.63%) 0.00% 0.00%
Return on equity (94.54%) 0.00% (50.12%)
Return on assets (21.02%) 0.00% (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CLLS TLSA Biotechnology median
Revenue growth (TTM) 0.61% — 6.26%
EPS growth (last fiscal year) (63.41%) (45.45%) 29.88%
Revenue growth, 5-year CAGR (0.70%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLLS TLSA Biotechnology median
Debt to equity 1.79 0.00 0.00
Current ratio 1.37 0.76 4.89
Net debt to EBITDA 9.54 0.19 1.01

Dividend

Metric CLLS TLSA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CLLS TLSA Biotechnology median
Market cap 84.63m 81.86m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack